Home ›
Trademark Categories ›
Pharmaceuticals ›
2012 ›
PR ›
PRIDALEZE
Trademark search for:
PRIDALEZE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2012-12-19 — Application filed
2013-01-24 — Sn assigned for sect 66a appl from ib
2013-01-28 — Application filed
2013-02-01 — Application filed
2013-03-22 — Assigned to examiner
2013-03-24 — Final disposition recorded
2013-03-25 — Office action issued
2013-03-26 — Office action issued
2013-03-26 — Office action issued
2013-04-16 — Office action issued
2013-09-11 — Teas/email correspondence entered
2013-09-11 — Office action issued
2013-09-11 — Correspondence received in law office
2013-09-26 — Approved for pub - principal register
2013-10-09 — Assigned to lie
2013-10-09 — Law office publication review completed
2013-10-23 — Notification of notice of publication e-mailed
2013-11-12 — Published for opposition
2013-11-12 — Official gazette publication confirmation e-mailed
2014-01-28 — Registered-principal register
2014-04-28 — Final disposition recorded
2014-06-13 — Final disposition recorded
2014-06-13 — Final disposition recorded
2014-07-04 — Final disposition recorded
2019-01-28 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2019-02-08 — Teas change of correspondence received
2021-02-26 — Cancelled section 71
2021-10-26 — Total invalidation of reg ext protection created
2022-01-26 — Total invalidation of reg ext protection sent to ib
2022-01-26 — Invalidation processed
2022-02-26 — Total invalidation processed by the ib
2022-12-19 — Final status recorded
2023-07-19 — Death of international registration
2023-07-19 — Notification of effect of cancellation of intl reg e-mailed
Owner Information
AstraZeneca AB
AstraZeneca AB
AstraZeneca AB
Correspondent
Wm. Charles Saunders ASTRAZENECA PHARMACEUTICALS LP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
